| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 3,439,877 | 3,376,420 | 3,386,429 | 3,334,431 | | Cost of Revenue | 579,829 | 747,820 | 859,350 | 914,282 | | | Gross Profit | 2,860,048 | 2,628,600 | 2,527,079 | 2,420,149 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,302,075 | 1,273,553 | 1,345,197 | 1,266,425 | | Non Recurring | 11,723 | (39,124) | 76,930 |
-
| | Others | 473,264 | 641,323 | 751,706 | 171,840 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,072,986 | 752,848 | 353,246 | 981,884 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,072,986 | 752,848 | 353,246 | 981,884 | | Interest Expense | 329,820 | 370,645 | 421,838 | 408,822 | | Income Before Tax | 743,166 | 382,203 | (68,592) | 573,062 | | Income Tax Expense | 202,804 | 91,648 | (79,716) | 152,898 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 540,362 | 290,555 | 11,124 | 420,164 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 540,362 | 290,555 | 11,124 | 420,164 | | Preferred Stock And Other Adjustments | (5,112) | (6,977) | (7,867) | (7,526) | | | Net Income Applicable To Common Shares | $535,250 | $283,578 | $3,257 | $412,638 |
|
3.31% Nasdaq 
Income Statement
